BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32711110)

  • 1. Liver X receptor inhibits the growth of hepatocellular carcinoma cells via regulating HULC/miR-134-5p/FOXM1 axis.
    He J; Yang T; He W; Jiang S; Zhong D; Xu Z; Wei Q; Zhang Y; Shi C
    Cell Signal; 2020 Oct; 74():109720. PubMed ID: 32711110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR-383-5p/vesicle-associated membrane protein-2 axis.
    Li P; Li Y; Ma L
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00815. PubMed ID: 34223709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA highly up-regulated in liver cancer promotes exosome secretion.
    Cao SQ; Zheng H; Sun BC; Wang ZL; Liu T; Guo DH; Shen ZY
    World J Gastroenterol; 2019 Sep; 25(35):5283-5299. PubMed ID: 31558873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma and its downregulation suppressed cancer cell development through endogenously competing against hsa-miR-485-5p.
    Peng Y; Leng W; Duan S; Hong M
    Biomed Pharmacother; 2019 Aug; 116():109027. PubMed ID: 31174090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA HULC promotes hepatocellular carcinoma progression.
    Zhang H; Liao Z; Liu F; Su C; Zhu H; Li Y; Tao R; Liang H; Zhang B; Zhang X
    Aging (Albany NY); 2019 Oct; 11(20):9111-9127. PubMed ID: 31645479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [LncRNA HULC promots HCC growth by downregulating miR-29].
    Zhu LR; Feng JL; Liu XJ; Wang JM
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
    [No Abstract]   [Full Text] [Related]  

  • 9. MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1.
    Zheng WW; Zhou J; Zhang CH; Liu XS
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2541-50. PubMed ID: 27383303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma.
    Tian C; Wu H; Li C; Tian X; Sun Y; Liu E; Liao X; Song W
    Gene Ther; 2018 Jul; 25(4):312-319. PubMed ID: 29973656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
    Xiong H; Ni Z; He J; Jiang S; Li X; He J; Gong W; Zheng L; Chen S; Li B; Zhang N; Lyu X; Huang G; Chen B; Zhang Y; He F
    Oncogene; 2017 Jun; 36(25):3528-3540. PubMed ID: 28166203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A.
    Zhou C; Chen Z; Peng C; Chen C; Li H
    Cancer Biother Radiopharm; 2021 Mar; 36(2):211-219. PubMed ID: 32391716
    [No Abstract]   [Full Text] [Related]  

  • 14. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.
    Zhang B; Zhang Y; Zou X; Chan AW; Zhang R; Lee TK; Liu H; Lau EY; Ho NP; Lai PB; Cheung YS; To KF; Wong HK; Choy KW; Keng VW; Chow LM; Chan KK; Cheng AS; Ko BC
    J Pathol; 2017 Dec; 243(4):418-430. PubMed ID: 28862757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
    Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
    J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
    Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway.
    Cui M; Xiao Z; Wang Y; Zheng M; Song T; Cai X; Sun B; Ye L; Zhang X
    Cancer Res; 2015 Mar; 75(5):846-57. PubMed ID: 25592151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.